Clinical Trials Browser

Phase 1/2 × Pancreatic Neoplasms × zimberelimab × Clear all

NCT05419479 2026-02-24

Switch Maintenance in Pancreatic

Phase 1/2 Suspended

Gastrointestinal

Pancreatic Neoplasms